AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 172 filers reported holding AXSOME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $217 | +112.7% | 3,112 | +120.4% | 0.00% | – |
| Q2 2023 | $102 | +7.4% | 1,412 | -8.4% | 0.00% | – |
| Q1 2023 | $95 | -20.2% | 1,541 | 0.0% | 0.00% | – |
| Q4 2022 | $119 | -99.8% | 1,541 | 0.0% | 0.00% | – |
| Q3 2022 | $69,000 | +16.9% | 1,541 | 0.0% | 0.00% | – |
| Q2 2022 | $59,000 | -13.2% | 1,541 | 0.0% | 0.00% | – |
| Q1 2022 | $68,000 | +17.2% | 1,541 | 0.0% | 0.00% | – |
| Q4 2021 | $58,000 | +13.7% | 1,541 | 0.0% | 0.00% | – |
| Q3 2021 | $51,000 | -51.0% | 1,541 | 0.0% | 0.00% | – |
| Q2 2021 | $104,000 | -9.6% | 1,541 | -25.0% | 0.00% | – |
| Q1 2021 | $115,000 | -31.1% | 2,055 | 0.0% | 0.00% | – |
| Q4 2020 | $167,000 | +14.4% | 2,055 | 0.0% | 0.00% | – |
| Q3 2020 | $146,000 | -13.1% | 2,055 | 0.0% | 0.00% | – |
| Q2 2020 | $168,000 | +75.0% | 2,055 | +27.6% | 0.00% | – |
| Q1 2020 | $96,000 | -41.8% | 1,610 | 0.0% | 0.00% | – |
| Q4 2019 | $165,000 | +111.5% | 1,610 | -47.0% | 0.00% | – |
| Q2 2019 | $78,000 | – | 3,035 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |